Tevogen Bio Holdings (TVGN) Other Accumulated Expenses (2022 - 2026)

Tevogen Bio Holdings has reported Other Accumulated Expenses for 5 years, with the latest figure at $98830.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 78.68% year-over-year to $98830.0; the trailing twelve-month figure through Mar 2026 stood at $98830.0 (down 78.68% YoY), and the FY2025 full-year result was $331086.0, down 17.89% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $98830.0, down from $331086.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $463587.0 in Q1 2025, with the low at $61307.0 in Q3 2024.
• Historically, Other Accumulated Expenses has averaged $226872.4 across 5 years, with a median of $200000.0 in 2023.
• The largest YoY upside for Other Accumulated Expenses was 291.96% in 2025 against a maximum downside of 80.7% in 2025.
• Tevogen Bio Holdings' Other Accumulated Expenses stood at $140000.0 in 2022, then fell by 14.18% to $120149.0 in 2023, then soared by 235.61% to $403233.0 in 2024, then declined by 17.89% to $331086.0 in 2025, then slumped by 70.15% to $98830.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $98830.0 (Q1 2026), $331086.0 (Q4 2025), and $240296.0 (Q3 2025), per Business Quant data.